Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

121 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation

NCT01087294

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +15 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • National Marrow Donor Program Minneapolis, Minnesota, United States
View Trial Details
Completed

Efficacy of Acalabrutinib in Very Old or Frail Patients With Treatment-naïve or Relapsed/Refractory CLL

NCT04883749

Conditions
Chronic Lymphoid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Medizinische Universität Innsbruck Innsbruck, Austria
  • Hanusch Krankenhaus Vienna, Austria
  • Onkologische Schwerpunktpraxis Kurfürstendamm Berlin, Germany
  • Universitätsklinik Köln Cologne, Germany
View all 20 locations
View Trial Details
Completed

Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers

NCT00788684

Conditions
CD20-Positive Lymphoid Malignancies, Chronic Lymphoid Leukemia, Hematologic Diseases, +16 more
Locations
  • University of Arizona Cancer Center - North Campus /ID# 16721 Tucson, Arizona, United States
  • Stanford University School of Med /ID# 9782 Stanford, California, United States
  • Cleveland Clinic Main Campus /ID# 9784 Cleveland, Ohio, United States
  • Univ of Wisconsin Hosp/Clinics /ID# 21701 Madison, Wisconsin, United States
View Trial Details
Completed

Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)

NCT04716075

Conditions
Adverse Event, Bronchial Diseases, Bronchiolitis, +33 more
Locations
  • Szpital Kliniczny Przemienienia Pańskiego, Oddział Hematologii i Transplantacji Szpiku Poznan, Greater Poland Voivodeship, Poland
  • Instytut Hematologii i Transfuzjologii Warsaw, Masovian Voivodeship, Poland
  • Narodowy Intytut Onkologii im. M. Skłodowskiej-Curie Oddział w Krakowie, Pododdział Leczenia Nowotworów Układu Chłonnego Krakow, Małopolska, Poland
  • Klinika Transplantacji Szpiku i Onkohematologii; Centrum Onkologii Instytut im. M.Sklodowskiej-Curie, Oddz. w Gliwicach Gliwice, Silesian Voivodeship, Poland
View Trial Details
Completed

Sequential Regimen of Bendamustin-Debulking Followed by Obinutuzumab, Acalabrutinib and Venetoclax in Patients With Relapsed/Refractory CLL

NCT03787264

Conditions
Chronic Lymphoid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Universitätsklinik Köln Cologne, Germany
  • Gemeinschaftspraxis Hämatologie Onkologie Dresden, Germany
  • Gemeinschaftspraxis Mohm/Prange-Krex Dresden, Germany
  • Universitatsklinik Carl Gustav Carus Dresden, Germany
View all 17 locations
View Trial Details
Completed

Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma

NCT02920697

Conditions
B-Cell Non-Hodgkin Lymphoma (NHL), Blood Protein Disorders, Cardiovascular Diseases, +22 more
Locations
  • The Alfred Hospital Malignant Haematology & Stem Cell Transplantation Services Melbourne, Australia
  • Hopital Claude Huriez Lille, France
  • CHU de Nantes Nantes, France
  • Centre hospitalier Lyon Sud Pierre-Bénite, France
View all 18 locations
View Trial Details

Related conditions